Improvement of Care of Patients Undergoing Pancreaticoduodenectomy
- Conditions
- Pancreas CancerPancreatic Diseases
- Interventions
- Procedure: Analgesia via epidural catheterProcedure: Analgesia via wound catheter
- Registration Number
- NCT04668781
- Lead Sponsor
- Helsinki University Central Hospital
- Brief Summary
The study is a randomised controlled trial comparing the effectivity and impact of epidural analgesia and wound catheter analgesia in patients undergoing pancreaticoduodenectomy. The aim of the study is to examine whether there are a difference in perioperative fluid therapy and complication rates between the patients in epidural and wound catheter groups.
- Detailed Description
All patients undergoing pancreaticoduodenectomy in Helsinki University Hospital are recruited in the study. Patients meeting the inclusion criteria and giving consent to participate the study will be randomised to whether epidural analgesia group or wound catheter analgesia group. Both groups receive additional analgesia with intravenous PCA-oxycodone (patient controlled analgesia).
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
- age 18 years or over
- patients who undergo pancreaticoduodenectomy
- patients to whom are made a major vascular reconstruction
- patients with significant comorbidities and inability to use PCA
- regural use of strong opioids or drugs preoperatively
- patients with severe chronic pain issues
- chronic atrial fibrillation
- patients who refuse to take part to the study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Epidural analgesia Analgesia via epidural catheter - Wound catheter analgesia Analgesia via wound catheter -
- Primary Outcome Measures
Name Time Method The norepinephrine consumption Postoperative day 0 Norepinephrine consumption on POD 0
- Secondary Outcome Measures
Name Time Method Fluid volumes on PODs 0-4 Postoperative days 0-4 Intraoperative and postoperative fluid volumes
Oxycodone consumption Postoperative days 1-4 Intravenous PCA opioid consumption.
Hospital length of stay Postoperative days 0-60 Postoperative complications Postoperative days 0-90 Clavien-Dindo complications (scale 0-5), pancreatic fistulas (ISGPF definition, grade A-C), postpancreatectomy hemorrage (IPGPS definition, grade A-C), delayed gastric emptying (ISGPS definition, grade A-C).
Reoperation rates Postoperative days 0-90 Readmission rates Postoperative days 0-90 Mortality postoperative day 0-90
Trial Locations
- Locations (1)
Helsinki University Hospital
🇫🇮Helsinki, HUS, Finland